home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Pharmaceutical Nanotechnology: From Bench to Bedside

  July 19, 2017  
CfPA-The Center for Professional Advancement, Online Live
August 16, 2017 at 11:00 a.m.–12:30 p.m. (ET)

Who Should Attend?
This training will benefit professionals in the public and private sectors involved in the areas of drug development, clinical sciences, FDA law, patent law, regulatory science, biomedical research, nanomedicine and governmental affairs. 

Specifically, it will benefit academic researchers and scientists, professors, post-doctoral fellows, graduate and undergraduate students, physicians, engineers, patent lawyers, regulatory personnel, pharmaceutical and biotechnology industries, technology transfer officers, business managers, venture capitalists and policy makers. 

It will be of special interest to federal agencies such as the NIH, FDA, NASA, SBA, NSF, NIST, NCI, USDOC, US Army and the Patent Office. 

Course Description
Nanomedicine is driven by collaborative research, patenting, commercialization, business development, and technology transfer within diverse areas such as biomedical sciences, chemical engineering, biotechnology, physical sciences and information technology. This 90-minute accredited training webinar provides cutting-edge information and developments pertaining to nanomedical advances with a focus on pharmaceutical sciences. Creating medical products today, including nanomedical is a complex process that requires a multiple of scientific disciplines. This training discusses the enormous advances made in nanomedicine and will serve as a guide to translating nanomedical products from the bench to the bedside. It will address critical questions: Will nanomedicine stocks and venture-backed startups deliver? Will nanomedicine evolve into a stand-alone industry?  

Can't Make this LIVE Webinar? 
Simply select the On Demand option when registering and we will send you the link to view the recorded version.

This course will be available On Demand: August 16, 2017
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Dr. Raj Bawa, President, Bawa Biotech LLC and Adjunct Professor, Rensselaer Polytechnic Institute

Dr. Bawa is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm founded in 2002 and based in Ashburn, VA. He is an inventor, entrepreneur, professor and registered patent agent licensed to practice before the U.S. Patent & Trademark Office. Trained as a biochemist and microbiologist, he has extensive expertise in nanotechnology, pharmaceutical sciences, biotechnology, drug delivery and biodefense-related scientific, FDA regulatory and patent law issues. He is currently an adjunct professor of biological sciences at Rensselaer Polytechnic Institute (Troy, NY), the university where he obtained his doctoral degree in three years (biophysics/biochemistry). Dr. Bawa is a scientific advisor to Teva Pharmaceutical Industries (Israel) and has served as a principal investigator of National Cancer Institute SBIRs and reviewer for both the National Institutes of Health and the National Science Foundation. He has authored over 100 publications, coedited four books, presented or chaired at over 200 conferences worldwide and serves on the editorial boards of 10 peer-reviewed journals.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: jmorbit@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.